首页 > 最新文献

Laeknabladid最新文献

英文 中文
[Polypharmacy: Benefit or harm?] [多药治疗:益处还是害处?]
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-10-01 DOI: 10.17992/lbl.2023.10.759
Adalsteinn Gudmundsson
{"title":"[Polypharmacy: Benefit or harm?]","authors":"Adalsteinn Gudmundsson","doi":"10.17992/lbl.2023.10.759","DOIUrl":"https://doi.org/10.17992/lbl.2023.10.759","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41179082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evidence and lifestyle - New nordic recommendations about nutrition and diet - emphasis on sustainability]. [证据和生活方式-北欧关于营养和饮食的新建议-强调可持续性]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-09-01 DOI: 10.17992/lbl.2023.09.757
Inga Thorsdottir, Birna Thorisdottir, Alfons Ramel, Thorhallur Halldorsson
Evaluation of research as basis for recommendations about lifestyle is discussed and especially recommendations about nutrition. Nordic recommendations on nutrients and diet with emphasis on sustainability are published 2023. Randomized trials, the strongest background for evidence based knowledge, are sometimes not possible to use when studying the influence of lifestyle on health. A tool applied in the Nordic recommendations 2023 evaluates the strength of relation between exposures (nutrients and food groups) and outcomes (health and environment), where research methods are observed and an organized quality control applied. The Interngovernmental Panel on Climate Change (IPCC) estimates the share of food systems in global anthropogenic GHG emissions is 31% (23%-42%). Nations now work on cutting GHG emissions from food systems by strengthening food based dietary guidelines and including sustainability, which benefits both health and environment. The recommendations about nutrients 2023 use harmonized methods and new data on body size in the Nordics. The food based dietary guidelines 2023 meet people's requirements for nutrients and are healthy for the environment. Physicians and other health professions will have the possibility to stimulate people´s interest to adhere to the recommendations about nutrition and diet built on a stronger and broader basis than before.
讨论了作为生活方式建议基础的研究评价,特别是关于营养的建议。北欧关于营养和饮食的建议将于2023年出版,重点是可持续性。随机试验是基于证据的知识的最有力背景,但在研究生活方式对健康的影响时,有时不可能使用随机试验。《2023年北欧建议》中使用的一种工具评估了暴露(营养素和食物组)与结果(健康和环境)之间的关系强度,其中观察了研究方法并实施了有组织的质量控制。政府间气候变化专门委员会(IPCC)估计,粮食系统在全球人为温室气体排放中所占的份额为31%(23%-42%)。各国正在努力通过加强以食物为基础的饮食指南,并将可持续性纳入其中,从而减少粮食系统的温室气体排放,这对健康和环境都有好处。关于2023年营养素的建议使用了统一的方法和北欧人体型的新数据。《2023年以食物为基础的膳食指南》既满足了人们对营养的需求,又有利于环境健康。医生和其他卫生专业人员将有可能激发人们的兴趣,坚持建立在比以前更强大和更广泛基础上的关于营养和饮食的建议。
{"title":"[Evidence and lifestyle - New nordic recommendations about nutrition and diet - emphasis on sustainability].","authors":"Inga Thorsdottir, Birna Thorisdottir, Alfons Ramel, Thorhallur Halldorsson","doi":"10.17992/lbl.2023.09.757","DOIUrl":"https://doi.org/10.17992/lbl.2023.09.757","url":null,"abstract":"Evaluation of research as basis for recommendations about lifestyle is discussed and especially recommendations about nutrition. Nordic recommendations on nutrients and diet with emphasis on sustainability are published 2023. Randomized trials, the strongest background for evidence based knowledge, are sometimes not possible to use when studying the influence of lifestyle on health. A tool applied in the Nordic recommendations 2023 evaluates the strength of relation between exposures (nutrients and food groups) and outcomes (health and environment), where research methods are observed and an organized quality control applied. The Interngovernmental Panel on Climate Change (IPCC) estimates the share of food systems in global anthropogenic GHG emissions is 31% (23%-42%). Nations now work on cutting GHG emissions from food systems by strengthening food based dietary guidelines and including sustainability, which benefits both health and environment. The recommendations about nutrients 2023 use harmonized methods and new data on body size in the Nordics. The food based dietary guidelines 2023 meet people's requirements for nutrients and are healthy for the environment. Physicians and other health professions will have the possibility to stimulate people´s interest to adhere to the recommendations about nutrition and diet built on a stronger and broader basis than before.","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10483858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Unlicensed drugs in Iceland in the years 2020 and 2021 with comparison to Sweden in 2020]. [2020年和2021年冰岛无证药品与2020年瑞典的对比]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-09-01 DOI: 10.17992/lbl.2023.09.756
Armey Valdemarsdottir, Anna Bryndis Blondal, Hjalti Kristinsson

Introduction: Prescriptions of unlicensed drugs along with public discussion have increased in recent years. The cause of this increase is unclear.

Material and methods: This is a retrospective descriptive study of applications of unlicensed drugs in Iceland in the years 2020 and 2021, as well as applications in Sweden for the year 2020. Information was collected on unlicensed prescription applications, registered drugs and stock-out time. Information was analyzed and categorized to describe the scope of unlicensed prescriptions in the two countries during the study time.

Results: In Iceland, 49.161 applications were approved in 2020 and 46.581 in 2021. The most common reason for using unlicensed products was that no registered drug was on the market with the same ATC-number (Anatomical Therapeutic Chemical code) and formulation. Shortage of drug was the reason for unlicensed prescription in 8.8% of cases in 2020 and 7.6% in 2021. The list of the 50 most prescribed drugs included the same drugs in 70% of the cases in both years. The five most prescribed drugs were the same in both years. In Sweden, 38.458 applications were approved in 2020. Of the most prescribed unlicensed drug, 46% were as no registered drug with same ATC-number and dosage form was marketed.

Conclusion: Many unlicensed drugs, prescribed in Iceland, are the same year after year. Only a small part of the applications approved were due to shortage of drug. The use of drugs without marketing license in Iceland in 2020 was higher than in Sweden when adjusted for the size of the market and population. Getting the five most prescribed unlicensed drugs licensed in Iceland could reduce largely, the total of prescription of unlicensed drugs in Iceland.

导言:近年来,无证药物的处方随着公众讨论的增加而增加。这种增长的原因尚不清楚。材料和方法:这是对2020年和2021年冰岛无证药物应用以及2020年瑞典无证药物应用的回顾性描述性研究。收集有关无牌处方申请、注册药物及缺货时间的资料。对信息进行分析和分类,以描述研究期间两国无证处方的范围。结果:在冰岛,2020年有49.161份申请获得批准,2021年有46.581份。使用无证产品最常见的原因是市场上没有注册药物具有相同的atc编号(解剖治疗化学代码)和配方。药品短缺是导致无证处方的原因,2020年占8.8%,2021年占7.6%。在这两年中,处方最多的50种药物中,有70%的病例使用了相同的药物。在这两年中,处方最多的五种药物是相同的。在瑞典,2020年有38.458份申请获得批准。在处方最多的无牌药物中,46%是由于没有销售具有相同atc编号和剂型的注册药物。结论:冰岛许多未经许可的处方药年复一年都是一样的。批准的申请中只有一小部分是由于药品短缺。根据市场规模和人口进行调整后,2020年冰岛无销售许可药品的使用高于瑞典。让五种最常被开具的无证药品在冰岛获得许可,可以大大减少冰岛无证药品的处方总量。
{"title":"[Unlicensed drugs in Iceland in the years 2020 and 2021 with comparison to Sweden in 2020].","authors":"Armey Valdemarsdottir,&nbsp;Anna Bryndis Blondal,&nbsp;Hjalti Kristinsson","doi":"10.17992/lbl.2023.09.756","DOIUrl":"https://doi.org/10.17992/lbl.2023.09.756","url":null,"abstract":"<p><strong>Introduction: </strong>Prescriptions of unlicensed drugs along with public discussion have increased in recent years. The cause of this increase is unclear.</p><p><strong>Material and methods: </strong>This is a retrospective descriptive study of applications of unlicensed drugs in Iceland in the years 2020 and 2021, as well as applications in Sweden for the year 2020. Information was collected on unlicensed prescription applications, registered drugs and stock-out time. Information was analyzed and categorized to describe the scope of unlicensed prescriptions in the two countries during the study time.</p><p><strong>Results: </strong>In Iceland, 49.161 applications were approved in 2020 and 46.581 in 2021. The most common reason for using unlicensed products was that no registered drug was on the market with the same ATC-number (Anatomical Therapeutic Chemical code) and formulation. Shortage of drug was the reason for unlicensed prescription in 8.8% of cases in 2020 and 7.6% in 2021. The list of the 50 most prescribed drugs included the same drugs in 70% of the cases in both years. The five most prescribed drugs were the same in both years. In Sweden, 38.458 applications were approved in 2020. Of the most prescribed unlicensed drug, 46% were as no registered drug with same ATC-number and dosage form was marketed.</p><p><strong>Conclusion: </strong>Many unlicensed drugs, prescribed in Iceland, are the same year after year. Only a small part of the applications approved were due to shortage of drug. The use of drugs without marketing license in Iceland in 2020 was higher than in Sweden when adjusted for the size of the market and population. Getting the five most prescribed unlicensed drugs licensed in Iceland could reduce largely, the total of prescription of unlicensed drugs in Iceland.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10483855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Quis custodiet medicum?] [谁留着医生?]
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-09-01 DOI: 10.17992/lbl.2023.09.755
Tryggvi Helgason
{"title":"[Quis custodiet medicum?]","authors":"Tryggvi Helgason","doi":"10.17992/lbl.2023.09.755","DOIUrl":"10.17992/lbl.2023.09.755","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10483861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Physician innovators]. [医生创新者]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-09-01 DOI: 10.17992/lbl.2023.09.754
Gunnar Thorarensen
{"title":"[Physician innovators].","authors":"Gunnar Thorarensen","doi":"10.17992/lbl.2023.09.754","DOIUrl":"10.17992/lbl.2023.09.754","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10483856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The many faces of Group A Streptococcal infections, case-series of invasive infections in children in Iceland]. [冰岛儿童A群链球菌感染的多面性,侵袭性感染病例系列]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-09-01 DOI: 10.17992/lbl.2023.09.758
Elin Ola Klemenzdottir, Arna Yr Karelsdottir, Valtyr Stefansson Thors

In recent months the incedence of invasive group A streptococcal infections (Streptococcus pyogenes) has increased worldwide. In the Children's Hospital Iceland 20 such cases were admitted during a four month period, until which time the avarage was one or two children admitted with an invasive GAS infection per year. To demonstrate the variability in the presentation of these invasive infections four cases were chosen for discussion in this case-series. Empyema with toxic shock syndrome, meningitis, orbital abscess and fascitis of the leg are reviewed.

近几个月来,世界范围内侵袭性A群链球菌感染(化脓性链球菌)的发病率有所上升。冰岛儿童医院在四个月内收治了20例此类病例,在此之前,平均每年有一至两名儿童因侵入性气体感染入院。为了证明这些侵袭性感染的表现的可变性,在这个病例系列中选择了四个病例进行讨论。脓胸合并中毒性休克综合征,脑膜炎,眶脓肿和腿筋膜炎的回顾。
{"title":"[The many faces of Group A Streptococcal infections, case-series of invasive infections in children in Iceland].","authors":"Elin Ola Klemenzdottir,&nbsp;Arna Yr Karelsdottir,&nbsp;Valtyr Stefansson Thors","doi":"10.17992/lbl.2023.09.758","DOIUrl":"https://doi.org/10.17992/lbl.2023.09.758","url":null,"abstract":"<p><p>In recent months the incedence of invasive group A streptococcal infections (Streptococcus pyogenes) has increased worldwide. In the Children's Hospital Iceland 20 such cases were admitted during a four month period, until which time the avarage was one or two children admitted with an invasive GAS infection per year. To demonstrate the variability in the presentation of these invasive infections four cases were chosen for discussion in this case-series. Empyema with toxic shock syndrome, meningitis, orbital abscess and fascitis of the leg are reviewed.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10483864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[To cause no harm. Use and misuse of proton pump inhibitors]. 不造成伤害。质子泵抑制剂的使用和误用]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.17992/lbl.2023.0708.750
Gudjon Kristjansson
{"title":"[To cause no harm. Use and misuse of proton pump inhibitors].","authors":"Gudjon Kristjansson","doi":"10.17992/lbl.2023.0708.750","DOIUrl":"https://doi.org/10.17992/lbl.2023.0708.750","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9689667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Methylphenidate-induced psychosis in a young adult with newly diagnosed ADHD: A case report]. [甲哌醋酯诱发的新诊断ADHD的年轻成人精神病:一例报告]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.17992/lbl.2023.0708.753
Ragna Kristin Gudbrandsdottir, Engilbert Sigurdsson, Oddur Ingimarsson

In view of the ongoing rise of ADHD prescriptions among adults in Iceland, it is important that doctors are aware that psychosis is a rare but at times a serious adverse reaction to such treatment. In 2022 5% of adults were prescribed medication to treat ADHD in Iceland. In this case report we present a case of methylphenidate-induced psychosis in a young man with no previous history of psychotic episodes who required admission to the psychiatric intensive care unit.

鉴于冰岛成年人中多动症处方的持续增加,医生们意识到精神病是一种罕见的疾病,但有时会对这种治疗产生严重的不良反应,这一点很重要。2022年,冰岛5%的成年人接受了治疗多动症的处方药。在这个病例报告中,我们提出了一例哌甲酯诱发的精神病,在一个年轻的男子没有精神病发作的历史,谁需要入院精神重症监护病房。
{"title":"[Methylphenidate-induced psychosis in a young adult with newly diagnosed ADHD: A case report].","authors":"Ragna Kristin Gudbrandsdottir,&nbsp;Engilbert Sigurdsson,&nbsp;Oddur Ingimarsson","doi":"10.17992/lbl.2023.0708.753","DOIUrl":"https://doi.org/10.17992/lbl.2023.0708.753","url":null,"abstract":"<p><p>In view of the ongoing rise of ADHD prescriptions among adults in Iceland, it is important that doctors are aware that psychosis is a rare but at times a serious adverse reaction to such treatment. In 2022 5% of adults were prescribed medication to treat ADHD in Iceland. In this case report we present a case of methylphenidate-induced psychosis in a young man with no previous history of psychotic episodes who required admission to the psychiatric intensive care unit.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9689670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[How can Artificial Intelligence be of use in the Healthcare System?] [人工智能如何应用于医疗保健系统?]]
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.17992/lbl.2023.0708.749
Steindor Ellertsson
{"title":"[How can Artificial Intelligence be of use in the Healthcare System?]","authors":"Steindor Ellertsson","doi":"10.17992/lbl.2023.0708.749","DOIUrl":"https://doi.org/10.17992/lbl.2023.0708.749","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9696321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Postpartum hemorrhage in singleton births in Iceland 2013 - 2018, incidence proportion and risk factors]. [冰岛2013 - 2018年单胎产后出血发生率及危险因素分析]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.17992/lbl.2023.0708.751
Karen Sol Saevarsdottir, Emma M Swift, Kristjana Einarsdottir, Johanna Gunnarsdottir

Introduction: Many countries have reported an increased incidence proportion of postpartum hemorrhage (PPH). The proportion might also have increased at the National University Hospital of Iceland, based on the registration of the ICD-10 code O72. This study aimed to assess the incidence proportion and risk factors for ≥1000 ml PPH in singleton births in Iceland 2013-2018.

Methods: This population-based cohort study included data from the Icelandic Birth register on 21.110 singleton births in 2013-2018. Incidence proportion of PPH was assessed based on three definitions: PPH >500 ml, PPH ≥1000 ml, and O72. Binomial regression was used to assess both the change in the proportion of ≥1000 ml PPH over time, stratified by maternal BMI, and risk factors for ≥1000 ml PPH.

Results: There was an inconsistency in the proportion of PPH when defined by blood loss >500 ml and O72. In obese women, PPH ≥1000 ml was more than twice as likely in those delivering in 2018 compared with 2013 (OR 2.23; CI 1.35-3.81). The strongest risk factors were emergency cesarean (OR 2.68; CI 2.22-3.22) and instrumental delivery (OR 2.18; CI 1.80-2.64), but macrosomia, primiparity and BMI ≥30 were also independent risk factors.

Conclusion: The incidence proportion of ≥1000 ml PPH has increased among obese women. The detrimental health effects of obesity and the increased prevalence of interventions among these women could explain these results. It is necessary to use registered blood loss in milliliters in the Icelandic Birth Register because of the under-registration of the diagnostic code O72.

导读:许多国家都报道了产后出血(PPH)的发病率增加。根据ICD-10代码O72的登记情况,冰岛国立大学医院的这一比例可能也有所增加。本研究旨在评估冰岛2013-2018年单胎分娩PPH≥1000 ml的发生率及危险因素。方法:这项基于人群的队列研究纳入了2013-2018年冰岛出生登记册中21.110例单胎出生的数据。根据PPH >500 ml、PPH≥1000 ml和O72三个定义评估PPH的发生率。采用二项回归评估PPH≥1000ml的比例随时间的变化(按母亲BMI分层)和PPH≥1000ml的危险因素。结果:以出血量>500 ml和O72定义PPH的比例不一致。在肥胖女性中,2018年分娩的女性PPH≥1000 ml的可能性是2013年的两倍多(OR 2.23;可信区间1.35 - -3.81)。最强危险因素为急诊剖宫产(OR 2.68;CI 2.22-3.22)和仪器输送(OR 2.18;CI 1.80-2.64),但巨大儿、初产和BMI≥30也是独立危险因素。结论:肥胖女性PPH≥1000ml的发生率有所增加。肥胖对健康的有害影响和干预措施在这些妇女中越来越普遍可以解释这些结果。由于诊断代码O72未登记,因此必须在冰岛出生登记册中使用以毫升为单位登记的失血量。
{"title":"[Postpartum hemorrhage in singleton births in Iceland 2013 - 2018, incidence proportion and risk factors].","authors":"Karen Sol Saevarsdottir,&nbsp;Emma M Swift,&nbsp;Kristjana Einarsdottir,&nbsp;Johanna Gunnarsdottir","doi":"10.17992/lbl.2023.0708.751","DOIUrl":"https://doi.org/10.17992/lbl.2023.0708.751","url":null,"abstract":"<p><strong>Introduction: </strong>Many countries have reported an increased incidence proportion of postpartum hemorrhage (PPH). The proportion might also have increased at the National University Hospital of Iceland, based on the registration of the ICD-10 code O72. This study aimed to assess the incidence proportion and risk factors for ≥1000 ml PPH in singleton births in Iceland 2013-2018.</p><p><strong>Methods: </strong>This population-based cohort study included data from the Icelandic Birth register on 21.110 singleton births in 2013-2018. Incidence proportion of PPH was assessed based on three definitions: PPH >500 ml, PPH ≥1000 ml, and O72. Binomial regression was used to assess both the change in the proportion of ≥1000 ml PPH over time, stratified by maternal BMI, and risk factors for ≥1000 ml PPH.</p><p><strong>Results: </strong>There was an inconsistency in the proportion of PPH when defined by blood loss >500 ml and O72. In obese women, PPH ≥1000 ml was more than twice as likely in those delivering in 2018 compared with 2013 (OR 2.23; CI 1.35-3.81). The strongest risk factors were emergency cesarean (OR 2.68; CI 2.22-3.22) and instrumental delivery (OR 2.18; CI 1.80-2.64), but macrosomia, primiparity and BMI ≥30 were also independent risk factors.</p><p><strong>Conclusion: </strong>The incidence proportion of ≥1000 ml PPH has increased among obese women. The detrimental health effects of obesity and the increased prevalence of interventions among these women could explain these results. It is necessary to use registered blood loss in milliliters in the Icelandic Birth Register because of the under-registration of the diagnostic code O72.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9689668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laeknabladid
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1